International Council for Harmonisation
The area of white adipocytes was determined using ImageJ software (NIH, Bethesda, MD, USA) by outlining white adipocytes with ellipses
Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: a subgroup analysis by baseline variables in the PIONEER 9 and PIONEER 10 trials
Starting doses vary by product: semaglutide typically starts at 0.25 mg weekly, dulaglutide at 0.75 mg weekly, tirzepatide at 2.5 mg weekly, while liraglutide begins at 0.6 mg daily
Trials with stratified data by age, disease status, and treatment duration will be instrumental in refining patient-centered prescribing practices
GLP-1s: Litigation, Enforcement, and Marketing Watchpoints Previously on the blog, we focused on the regulatory and compliance risks surrounding compounded GLP1 products, particularly misbranding, quality concerns, and how quickly the enforcement landscape has evolved